Showing 66,281 - 66,300 results of 66,758 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (nn decrease)) ))', query time: 1.57s Refine Results
  1. 66281

    Image 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.jpeg by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  2. 66282

    Table 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  3. 66283

    Image 13_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  4. 66284

    Table 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  5. 66285

    Image 10_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  6. 66286

    Image 5_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Post-HC CVL vs. pre-HC enhanced HIV infection of cells in vitro for all three HC groups (p<0.01) and was modified by the vaginal microbiome. …”
  7. 66287

    Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod by Zi-Ye Song (731226)

    Published 2015
    “…Eight relapsed patients demonstrated greater percentages of CD4<sup>+</sup>TCM than 15 non-relapsed patients at 3 and 6 months (<i>p</i>=0.0051 and <i>p</i>=0.0088, respectively). The IL17-, IL9-, and IL4-producing CD4<sup>+</sup>T cell percentages were significantly higher at pre-treatment in MS patients compared with HCs (<i>p</i><0.01 for all), while the IL17-producing CD4<sup>+</sup>T cell percentages tended to show a transient increase at 2 weeks of fingolimod therapy (<i>p<sup>corr</sup></i>=0.0834).…”
  8. 66288
  9. 66289

    Validation of E. coli Signaling Network Model by Burton W Andrews (274358)

    Published 2013
    “…<div><p>(A) Response of the E. coli signaling network model is plotted for a 0.1-mM step increase in chemoattractant concentration from 0.2 mM at 10 s. …”
  10. 66290

    AOX inhibitor supresses growth of <i>T</i>. <i>hominis</i> cells inside the RK13 host cells at early meront stages of the infection, and affects the ability to infect by the spores... by Kacper M. Sendra (14285356)

    Published 2022
    “…ANOVA analysis was used to test significance of the differences between the measured values (****, P ≤ 0.0001; ***, P ≤ 0.001; **, P ≤ 0.01; *, P ≤ 0.05). …”
  11. 66291

    Behavioral comparisons in the open field test. by Kate Lykke Lambertsen (127171)

    Published 2012
    “…Data are given as means ± SEM.* P<0.05, ** P<0.01, *** P<0.001, unpaired Student's T-test (KCa3.1<sup>−/−</sup> vs. …”
  12. 66292

    Overexpression of TRα1, but not TRα2, in the hypothalamus modulates circulating T<sub>4</sub> levels. by Hajer Guissouma (586934)

    Published 2014
    “…Means ± SEM of pooled samples are given, n≥4 for each point. **, p<0.01.</p>…”
  13. 66293
  14. 66294

    FOXM1 directly binds to and induces transcriptional activity of <i>Dusp1</i> promoter in macrophages. by Chinmayee Goda (8694597)

    Published 2020
    “…<p><b>(A)</b> Depletion of <i>Foxm1</i> in macrophages decreased <i>Dusp1</i> mRNA and increased <i>Tnf</i>, <i>Il6</i> and <i>Il1b</i> mRNA. …”
  15. 66295

    Progressive synaptic deficits in the Katnal2-KO hippocampus. by Ryeonghwa Kang (6793046)

    Published 2024
    “…<p>(A–D) Decreased CBVs in various brain regions of Katnal2-KO mice, including the hippocampus surrounded by lateral ventricles, as compared with WT mice (3 months). …”
  16. 66296
  17. 66297
  18. 66298
  19. 66299
  20. 66300